MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
43 hedge funds and large institutions have $48.1M invested in Merrimack Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less capital invested
Capital invested by funds: $49.5M → $48.1M (-$1.4M)
59% less call options, than puts
Call options by funds: $117K | Put options by funds: $283K
Holders
43
Holding in Top 10
1
Calls
$117K
Puts
$283K
Top Buyers
| 1 | +$578K | |
| 2 | +$264K | |
| 3 | +$161K | |
| 4 |
SC
Sepio Capital
Salt Lake City,
Utah
|
+$118K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$97K |
Top Sellers
| 1 | -$151K | |
| 2 | -$84K | |
| 3 | -$39.1K | |
| 4 |
Two Sigma Investments
New York
|
-$34.6K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$34.4K |